Strides Arcolab announced its entry into biologics, with the signing of an agreement to acquire 70 per cent stake in biotechnology company Inbiopro Solutions, based in Bangalore.
Inbiopro is a biotech outsourced research start-up and has eight candidate products in oncology to begin with. Strides will invest Rs 65 crore over three years in the form of growth capital to develop and commercialise the eight products. The acquisition gives Strides immediate access to a pipeline of eight products estimated to have global sales of over $28 billion. Commercialisation of these products is expected to begin in 2013.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: